Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

AQU/PBX stock hub

AQU/PBX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AQU/PBXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.7M

Aquis Exchange

Market data

Live price

Current market quote for this ticker.

Current price

AQU/PBX

In the news

Latest news · AQU/PBX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-73.3

P25 n/aP50 n/aP75 n/a

ROIC-697.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AQU/PBX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

GBP

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	12
Employees Change	4%
Employees Change Percent	50
Enterprise value	GBX 11.4M
Exchange	Aquis Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	GBX 12.7M
Price	GBX 8
Price currency	GBX
Rev Per Employee	227,666.67x
Sic	2836
Symbol	aqu/PBX
Website	https://www.probiotixhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.74%
EV Earnings	-9.24x
EV/FCF	-30.05x
EV/Sales	4.17x
FCF yield	-3%
P/B ratio	8.77x
P/S ratio	4.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-45.2%
EBITDA Margin	-43.23%
Gross margin	54.25%
Gross Profit	GBX 1.5M
Gross Profit Growth	25.49%
Gross Profit Growth Q	69.52%
Gross Profit Growth3 Y	8.14%
Gross Profit Growth5 Y	16.34%
Net Income	GBX -1.2M
Pretax Margin	-45.2%
Profit Margin	-45.13%
Profit Per Employee	GBX -102,750
ROA	-38.74
Roa5y	-16.21
ROCE	-82.89
ROE	-73.26
ROIC	-697.7
Roic5y	-278.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.3%
Cagr3y	10.06%
Revenue Growth	45.09x
Revenue Growth Q	58.27x
Revenue Growth3 Y	8.7x
Revenue Growth5 Y	16.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 1.37
Assets	GBX 1.8M
Cash	GBX 1.3M
Current Assets	GBX 1.6M
Current Liabilities	GBX 318,000
Equity	GBX 1.4M
Liabilities	GBX 365,000
Long Term Assets	GBX 191,000
Long Term Liabilities	GBX 47,000
Net Cash	GBX 1.3M
Net Cash By Market Cap	GBX 10.01
Net Cash Growth	-23.09%
Net Debt Equity	GBX -0.88
Tangible Book Value	GBX 1.3M
Tangible Book Value Per Share	GBX 0.01
WACC	4.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.08
Net Working Capital	GBX 33,000
Quick ratio	4.99
Working Capital	GBX 1.3M
Working Capital Turnover	GBX 1.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.29%
200-day SMA	7.91
3Y total return	33.33%
50-day SMA	7.82
50-day SMA vs 200-day SMA	50under200
All Time High	24
All Time High Change	-66.67%
All Time High Date	2022-09-20
All Time Low	2.5
All Time Low Change	220%
All Time Low Date	2024-08-01
ATR	0.08
Beta	-0.01
Beta1y	0.54
Beta2y	0.81
Ch YTD	3.23
High52	10
High52 Date	2025-07-31
High52ch	-20%
Low52	5.75
Low52 Date	2026-03-20
Low52ch	39.13%
Ma50ch	2.37%
Price vs 200-day SMA	1.18%
RSI	54.25
RSI Monthly	48.59
RSI Weekly	51.63
Sharpe ratio	0.48x
Sortino ratio	0.97
Total Return	-18.51%
Tr YTD	3.23
Tr1m	1.59%
Tr3m	3.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -1.2M
Operating margin	-45.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Out	158,166,666
Shares Qo Q	0%
Shares Yo Y	18.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -1.1M
Average Volume	0x
Bv Per Share	0.01
CAPEX	GBX -12,000
Ch1m	1.59
Ch1y	14.29
Ch3m	3.23
Ch3y	33.33
Ch6m	3.23
Change	0%
Close	8
Depreciation Amortization	54,000
Earnings Date	2026-05-29
EBIT	GBX -1.2M
EBITDA	GBX -1.2M
EPS	GBX -0.01
F Score	4
FCF	GBX -379,000
FCF EV Yield	-3.33x
FCF Per Share	GBX -0
Fiscal Year End	December
Founded	2,012
Income Tax	GBX -2,000
Investing CF	-12,000
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma150	7.73
Ma150ch	3.48%
Ma20	7.99
Ma20ch	0.08%
Net CF	-380,000
Next Earnings Date	2026-05-29
Ppne	5,000
Price Date	2026-05-08
Ptbv Ratio	10.07
Revenue	2,732,000x
SBC By Revenue	27.56x
Share Based Comp	753,000
Tax By Revenue	-0.07x
Tr6m	3.23%
Z Score	18.91

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AQU/PBX pay a dividend?

Capital-return profile for this ticker.

Performance

AQU/PBX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AQU/PBX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+18.5%

Negative means the company is buying back shares.

Technical

AQU/PBX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.2

Neutral momentum band

Price vs 200-day MA

+1.2%

50/200-day relationship not available

Beta (5Y)

-0.01

Less volatile than the market

Sharpe ratio

0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AQU/PBX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aqu/PBX stock rating?

aqu/PBX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aqu/PBX analysis?

The full report lives at /stocks/aqu/PBX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aqu/PBX?

The latest report frames aqu/PBX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aqu/PBX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.